Neoadjuvant Anlotinib and chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced esophageal squamous cell carcinoma: Short-term results of an open-label, randomized, phase II trial

समान संसाधन

• Minimal invasive versus open esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant treatments
  द्वारा: Dongni Chen, और अन्य
  प्रकाशित: (2021-02-01)
• Prognostic role of the pathological status following neoadjuvant chemoradiotherapy and surgery in esophageal squamous cell carcinoma
  द्वारा: Xiaofeng Duan, और अन्य
  प्रकाशित: (2025-01-01)
• CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596)
  द्वारा: Han Tang, और अन्य
  प्रकाशित: (2017-06-01)
• Reliability and safety of minimally invasive esophagectomy after neoadjuvant chemoradiation: a retrospective study
  द्वारा: Guangyuan Liu, और अन्य
  प्रकाशित: (2019-05-01)
• Impact of perioperative decreased serum albumin level on anastomotic leakage in esophageal squamous cell carcinoma patients treated with neoadjuvant chemotherapy followed by minimally invasive esophagectomy
  द्वारा: Ying-Jian Wang, और अन्य
  प्रकाशित: (2023-12-01)